# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-24-047510
Filing Date
2024-04-16
Accepted
2024-04-16 08:00:24
Documents
60
Period of Report
2024-04-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2411908d1_8k.htm iXBRL | 8-K | 28410
2 | EXHIBIT 99.1 | tm2411908d1_ex99-1.htm | EX-99.1 | 71228
6 | GRAPHIC | tm2411908d1_ex99-1img001.jpg | GRAPHIC | 160407
7 | GRAPHIC | tm2411908d1_ex99-1img002.jpg | GRAPHIC | 347900
8 | GRAPHIC | tm2411908d1_ex99-1img003.jpg | GRAPHIC | 177786
9 | GRAPHIC | tm2411908d1_ex99-1img004.jpg | GRAPHIC | 170423
10 | GRAPHIC | tm2411908d1_ex99-1img005.jpg | GRAPHIC | 153248
11 | GRAPHIC | tm2411908d1_ex99-1img006.jpg | GRAPHIC | 210451
12 | GRAPHIC | tm2411908d1_ex99-1img007.jpg | GRAPHIC | 212628
13 | GRAPHIC | tm2411908d1_ex99-1img008.jpg | GRAPHIC | 228561
14 | GRAPHIC | tm2411908d1_ex99-1img009.jpg | GRAPHIC | 220294
15 | GRAPHIC | tm2411908d1_ex99-1img010.jpg | GRAPHIC | 176031
16 | GRAPHIC | tm2411908d1_ex99-1img011.jpg | GRAPHIC | 219875
17 | GRAPHIC | tm2411908d1_ex99-1img012.jpg | GRAPHIC | 166899
18 | GRAPHIC | tm2411908d1_ex99-1img013.jpg | GRAPHIC | 206774
19 | GRAPHIC | tm2411908d1_ex99-1img014.jpg | GRAPHIC | 193730
20 | GRAPHIC | tm2411908d1_ex99-1img015.jpg | GRAPHIC | 157275
21 | GRAPHIC | tm2411908d1_ex99-1img016.jpg | GRAPHIC | 173691
22 | GRAPHIC | tm2411908d1_ex99-1img017.jpg | GRAPHIC | 166195
23 | GRAPHIC | tm2411908d1_ex99-1img018.jpg | GRAPHIC | 172257
24 | GRAPHIC | tm2411908d1_ex99-1img019.jpg | GRAPHIC | 198310
25 | GRAPHIC | tm2411908d1_ex99-1img020.jpg | GRAPHIC | 156062
26 | GRAPHIC | tm2411908d1_ex99-1img021.jpg | GRAPHIC | 191144
27 | GRAPHIC | tm2411908d1_ex99-1img022.jpg | GRAPHIC | 165192
28 | GRAPHIC | tm2411908d1_ex99-1img023.jpg | GRAPHIC | 193114
29 | GRAPHIC | tm2411908d1_ex99-1img024.jpg | GRAPHIC | 210299
30 | GRAPHIC | tm2411908d1_ex99-1img025.jpg | GRAPHIC | 209389
31 | GRAPHIC | tm2411908d1_ex99-1img026.jpg | GRAPHIC | 186598
32 | GRAPHIC | tm2411908d1_ex99-1img027.jpg | GRAPHIC | 169747
33 | GRAPHIC | tm2411908d1_ex99-1img028.jpg | GRAPHIC | 200989
34 | GRAPHIC | tm2411908d1_ex99-1img029.jpg | GRAPHIC | 169171
35 | GRAPHIC | tm2411908d1_ex99-1img030.jpg | GRAPHIC | 173061
36 | GRAPHIC | tm2411908d1_ex99-1img031.jpg | GRAPHIC | 228657
37 | GRAPHIC | tm2411908d1_ex99-1img032.jpg | GRAPHIC | 170452
38 | GRAPHIC | tm2411908d1_ex99-1img033.jpg | GRAPHIC | 132205
39 | GRAPHIC | tm2411908d1_ex99-1img034.jpg | GRAPHIC | 184279
40 | GRAPHIC | tm2411908d1_ex99-1img035.jpg | GRAPHIC | 172771
41 | GRAPHIC | tm2411908d1_ex99-1img036.jpg | GRAPHIC | 152368
42 | GRAPHIC | tm2411908d1_ex99-1img037.jpg | GRAPHIC | 190588
43 | GRAPHIC | tm2411908d1_ex99-1img038.jpg | GRAPHIC | 230773
44 | GRAPHIC | tm2411908d1_ex99-1img039.jpg | GRAPHIC | 237721
45 | GRAPHIC | tm2411908d1_ex99-1img040.jpg | GRAPHIC | 185408
46 | GRAPHIC | tm2411908d1_ex99-1img041.jpg | GRAPHIC | 251001
47 | GRAPHIC | tm2411908d1_ex99-1img042.jpg | GRAPHIC | 340566
48 | GRAPHIC | tm2411908d1_ex99-1img043.jpg | GRAPHIC | 305754
49 | GRAPHIC | tm2411908d1_ex99-1img044.jpg | GRAPHIC | 200927
50 | GRAPHIC | tm2411908d1_ex99-1img045.jpg | GRAPHIC | 255808
51 | GRAPHIC | tm2411908d1_ex99-1img046.jpg | GRAPHIC | 220616
| Complete submission text file | 0001104659-24-047510.txt |  | 12965065

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | syn-20240416.xsd | EX-101.SCH | 3042
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | syn-20240416_lab.xml | EX-101.LAB | 34240
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | syn-20240416_pre.xml | EX-101.PRE | 22378
63 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2411908d1_8k_htm.xml | XML | 3692

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 24846134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)